The Russian Direct Investment Fund (RDIF) has partnered with Dr. Reddy’s to distribute Russia’s Sputnik V COVID-19 vaccine in India.
Under the agreement, Dr. Reddy’s will also collaborate with RDIF on clinical trials of the vaccine in India. Upon its approval by India’s regulatory authority, RDIF will supply Dr. Reddy’s with 100 million doses for distribution within the country.
RDIF last week partnered with Landsteiner Scientific to distribute 32 million doses of the vaccine in Mexico.
Leave a Reply